Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents

Overview of attention for article published in Journal of Hematology & Oncology, August 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents https://t.co/7BiGbF8aSh #MDS #mdssm #hematology https://t.co/zBwXmDO16q

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.